Fingerprint
Dive into the research topics of 'A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically